Literature DB >> 3987715

A case of lipogranulomatosis Farber: some clinical and ultrastructural aspects.

U Burck, H W Moser, H H Goebel, R Grüttner, K R Held.   

Abstract

A 20-month-old girl showed typical clinical signs of Farber disease: hoarseness since birth, and periarticular subcutaneous painful nodules. Complete deficiency of acid ceramidase activity was found in cultured skin fibroblasts. An electron microscopic examination of a dermal nodule disclosed pathognomonic tubular inclusions in histiocytes. In epidermal cells zebra-body-like and needle-like lysosomal inclusions were found. Their ultrastructure is different from that of the intrahistiocytic lysosomal inclusions. Probably three clinical types of Farber disease may be distinguished according to the symptomatology and the course of the disease: a severe type, an intermediate type and a relatively mild type. The activity of acid ceramidase does not correlate with prognosis of the disease, while a correlation between first appearance of dermal nodules and clinical course appears likely.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987715     DOI: 10.1007/bf00442139

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  18 in total

1.  A lipid metabolic disorder: disseminated lipogranulomatosis; a syndrome with similarity to, and important difference from, Niemann-Pick and Hand-Schüller-Christian disease.

Authors:  S FARBER
Journal:  AMA Am J Dis Child       Date:  1952-10

2.  [Farber's disease. Anatomoclinical and ultrastructural study].

Authors:  P Dustin; M Tondeur; G Jonniaux; E Vamos-Hurwitz; S Pelc
Journal:  Bull Acad R Med Belg       Date:  1974-10

3.  [A rare neurolipidosis with subcutaneous and articular node lesions: disseminated Farber's lipogranulomatosis].

Authors:  J Battin; C Vital; X Azanza
Journal:  Ann Dermatol Syphiligr (Paris)       Date:  1970

4.  Glycosphingolipids and ceramides in human and pig epidermis.

Authors:  G M Gray; R J White
Journal:  J Invest Dermatol       Date:  1978-06       Impact factor: 8.551

5.  [Farber's lipogranulomatosis].

Authors:  H Barrière; F Gillot
Journal:  Nouv Presse Med       Date:  1972-03

6.  Ceramidase deficiency in Farber's disease (lipogranulomatosis).

Authors:  M Sugita; J T Dulaney; H W Moser
Journal:  Science       Date:  1972-12-08       Impact factor: 47.728

7.  Farber's disease as a ceramidosis: clinical, radiological and biochemical aspects.

Authors:  M Toppet; E Vamos-Hurwitz; G Jonniaux; N Cremer; M Tondeur; S Pelc
Journal:  Acta Paediatr Scand       Date:  1978-01

8.  Farber's lipogranulomatosis: ceramidase deficiency and prolonged survival in three relatives.

Authors:  L Pavone; H W Moser; F Mollica; C Reitano; P Durand
Journal:  Johns Hopkins Med J       Date:  1980-11

9.  On the ultrastructural diversity and essence of residual bodies in neuronal ceroid-lipofuscinosis.

Authors:  H H Goebel; W Zeman; V K Patel; R K Pullarkat; H G Lenard
Journal:  Mech Ageing Dev       Date:  1979-04       Impact factor: 5.432

10.  [Ultrastructural aspects of peripheral nerve lesions in one case of Farber's disease].

Authors:  C Vital; J Battin; J Rivel; J P Hehunstre
Journal:  Rev Neurol (Paris)       Date:  1976-06       Impact factor: 2.607

View more
  8 in total

Review 1.  Farber disease: an ultrastructural study. Report of a case and review of the literature.

Authors:  L Zappatini-Tommasi; C Dumontel; P Guibaud; C Girod
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Farber's disease without central nervous system involvement: bone-marrow transplantation provides a promising new approach.

Authors:  K Ehlert; J Roth; M Frosch; N Fehse; N Zander; J Vormoor
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

3.  Markedly perturbed hematopoiesis in acid ceramidase deficient mice.

Authors:  Shaalee Dworski; Alexandra Berger; Caren Furlonger; Joshua M Moreau; Makoto Yoshimitsu; Jessa Trentadue; Bryan C Y Au; Christopher J Paige; Jeffrey A Medin
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

4.  Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities.

Authors:  Jakub Sikora; Shaalee Dworski; E Ellen Jones; Mustafa A Kamani; Matthew C Micsenyi; Tomo Sawada; Pauline Le Faouder; Justine Bertrand-Michel; Aude Dupuy; Christopher K Dunn; Ingrid Cong Yang Xuan; Josefina Casas; Gemma Fabrias; David R Hampson; Thierry Levade; Richard R Drake; Jeffrey A Medin; Steven U Walkley
Journal:  Am J Pathol       Date:  2017-04       Impact factor: 4.307

5.  Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels.

Authors:  Oshrit Ben-David; Yael Pewzner-Jung; Ori Brenner; Elad L Laviad; Aviram Kogot-Levin; Itai Weissberg; Inbal E Biton; Reut Pienik; Elaine Wang; Samuel Kelly; Joseph Alroy; Annick Raas-Rothschild; Alon Friedman; Britta Brügger; Alfred H Merrill; Anthony H Futerman
Journal:  J Biol Chem       Date:  2011-06-24       Impact factor: 5.157

6.  Identification of ASAH1 as a susceptibility gene for familial keloids.

Authors:  Regie Lyn P Santos-Cortez; Ying Hu; Fanyue Sun; Fairouz Benahmed-Miniuk; Jian Tao; Jitendra K Kanaujiya; Samuel Ademola; Solomon Fadiora; Victoria Odesina; Deborah A Nickerson; Michael J Bamshad; Peter B Olaitan; Odunayo M Oluwatosin; Suzanne M Leal; Ernst J Reichenberger
Journal:  Eur J Hum Genet       Date:  2017-07-26       Impact factor: 4.246

7.  A case of combined Farber and Sandhoff disease.

Authors:  C Fusch; R Huenges; H W Moser; A C Sewell; W Roggendorf; B Kustermann-Kuhn; A Poulos; W F Carey; K Harzer
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

Review 8.  Acid ceramidase deficiency: Farber disease and SMA-PME.

Authors:  Fabian P S Yu; Samuel Amintas; Thierry Levade; Jeffrey A Medin
Journal:  Orphanet J Rare Dis       Date:  2018-07-20       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.